Iovance Biotherapeutics, Inc. (IOVA) Earnings History
Net Loss18 years of earnings data (2008–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Iovance Biotherapeutics, Inc. (IOVA) Earnings Overview
As of June 22, 2026, Iovance Biotherapeutics, Inc. (IOVA) reported trailing twelve-month net income of -$354M, reflecting +14.8% year-over-year growth. The company earned $-0.85 per diluted share over the past four quarters, with a net profit margin of -148.4%.
Looking at the long-term picture, IOVA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$15,772 in fiscal 2009.
Iovance Biotherapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ADCT (-$137M net income, -175.3% margin), FATE (-$130M net income, -2051.1% margin), CRSP (-$569M net income, -16569.8% margin), IOVA has outperformed on profitability metrics. Compare IOVA vs ADCT →
IOVA Earnings vs Peers
Earnings metrics vs comparable public companies
IOVA Historical Earnings Data (2008–2025)
18 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$391M | -5.1% | -$403M | $-1.09 | -148.4% | -153.1% |
| 2024 | -$372M | +16.2% | -$395M | $-1.28 | -226.8% | -240.9% |
| 2023 | -$444M | -12.2% | -$461M | $-1.89 | -37345.4% | -38735.0% |
| 2022 | -$396M | -15.7% | -$399M | $-2.49 | - | - |
| 2021 | -$342M | -31.8% | -$343M | $-2.23 | - | - |
| 2020 | -$260M | -31.4% | -$262M | $-1.88 | - | - |
| 2019 | -$198M | -59.9% | -$207M | $-1.50 | - | - |
| 2018 | -$124M | -34.2% | -$128M | $-1.27 | - | - |
| 2017 | -$92M | -74.1% | -$93M | $-1.41 | - | - |
| 2016 | -$53M | -91.2% | -$54M | $-0.96 | - | - |
| 2015 | -$28M | -129.8% | -$28M | $-0.62 | - | - |
| 2014 | -$12M | +52.6% | -$12M | $-0.48 | - | - |
| 2013 | -$25M | -667.3% | -$23M | $-2.60 | - | - |
| 2012 | -$3M | +87.1% | -$8M | $-4.14 | - | - |
| 2011 | -$26M | -1497.9% | -$21M | $-33.84 | - | - |
| 2010 | -$2M | -10095.3% | $-815,000 | $-2.46 | - | - |
| 2009 | $-15,772 | +72.4% | $-15,772 | $-0.02 | - | - |
| 2008 | $-57,140 | - | $-57,140 | $-0.05 | - | - |
Download Data
Export IOVA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
18+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
IOVA — Frequently Asked Questions
Quick answers to the most common questions about buying IOVA stock.
What is IOVA earnings per share (EPS)?
IOVA trailing twelve-month (TTM) diluted EPS is $-0.85, reflecting +14.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2008 to 2025 is available in the table on this page.
What is Iovance Biotherapeutics, Inc.'s net income?
Iovance Biotherapeutics, Inc. (IOVA) trailing twelve-month net income is $-354M as of 2025. Earnings grew +14.8% year-over-year.
Is IOVA profitable?
IOVA is not currently profitable on a TTM basis, reporting a net loss of $-354M. Net margin is -148.4%. Investors should monitor for a return to profitability.
What is IOVA's earnings growth rate?
IOVA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2008 to 2025.
What are IOVA's profit margins?
Iovance Biotherapeutics, Inc. net profit margin is -148.4%, operating margin is -153.1%, and gross margin is +97.2%. Below-average margins reflect competitive or cost pressures. Return on Equity is -55.5%.
Is IOVA growing earnings?
IOVA is growing earnings steadily. YoY EPS growth of +14.8% is consistent with the 5-year CAGR of N/A. TTM net income is $-354M.
What was IOVA's best earnings year?
Iovance Biotherapeutics, Inc.'s highest annual net income on record is $-15772.00, achieved in fiscal year 2009. Earnings history on this page spans 2008 to 2025 and includes all annual and quarterly figures.
What were IOVA's earnings last quarter?
IOVA's most recent reported quarter was Q1 2026. Net income was $-79M with diluted EPS of $-0.19. For a full breakdown of all quarters, see the quarterly earnings table on this page.